Clinical Trials in Maryland

Showing 12521-12540 of 19,983 trials

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

NCT03288376

This is a prospective multipart clinical performance study to compare the ability of the SnoreSounds algorithm with polysomnography (PSG) and a type III Home Sleep Testing (HST) device to identify patients with obstructive sleep apnea (OSA).

Sleep Apnea, ObstructiveChronic Obstructive Pulmonary Disease

Incyphae, Inc.272 participantsStarted Feb 2015

Burlingame, California, United States • New London, Connecticut, United States • Lanham, Maryland, United States

COMPLETEDPhase 215 miles

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

NCT01196429

This phase II trial studies how well temsirolimus, carboplatin, and paclitaxel as first-line therapy works in treating patients with newly diagnosed stage III-IV clear cell ovarian cancer. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving temsirolimus with combination chemotherapy may be an effective treatment for ovarian cancer.

Ovarian Clear Cell CystadenocarcinomaStage III Ovarian CancerStage IV Ovarian Cancer

National Cancer Institute (NCI)90 participantsStarted Aug 2010

Phoenix, Arizona, United States • Burbank, California, United States • Los Angeles, California, United States +142 more locations

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Find Trials by Condition in Maryland

Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)

Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome

Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion

Evaluating Ketamine and Psychological Sequelae

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Radiation Therapy in Treating Young Patients With Gliomas

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma

Novel Diagnostics for Early Lyme Disease

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Parent-Adolescent Interactions and Adolescent Development

Reevaluation Of Systemic Early Neuromuscular Blockade

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients

LOIS: Long-Term Follow-Up in INSITE/SIFI

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab